獣医ヘルスケア市場の2030年までの予測：製品別、疾患別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、世界の獣医ヘルスケア市場は2024年に460億7,000万米ドルを占め、予測期間中にCAGR 11.11％で成長し、2030年には866億9,000万米ドルに達すると予想されています。

獣医ヘルスケアは、動物の幸福と健康を促進することを目的とした医療サービスの広範なスペクトルを包含します。ペット、家畜、野生動物、エキゾチックアニマルを含む様々な動物種の予防措置、診断、治療、リハビリテーションが含まれます。獣医師は、外科学、内科学、歯科学、栄養学、行動学などの専門知識を通じて、動物の福祉、公衆衛生、環境を守る上で重要な役割を果たしています。その責務は、個々の動物のケアにとどまらず、疾病管理、ワクチン接種プログラム、医学知識の向上とヘルスケア成果の改善を目的とした調査にまで及ぶ。

米国ペット用品協会（American Pet Products Association）によると、獣医療への支出は着実に増加しており、米国の消費者は2021年に1,236億米ドルを獣医療と製品販売に費やしています。

ペット保険の増加

ペット保険に加入する人が増えたことで、緊急事態でなくても動物病院を受診する意欲が高まっています。この変化は、飼い主が動物の予防や定期的な治療を受けることを躊躇させるような経済的な障壁を軽減します。その結果、獣医師は患者数が増え、高度な設備や施設、トレーニングに投資できるようになり、全体的な治療の質が向上します。さらに、保険が適用されることで、飼い主は治療計画や経過観察の予約を守るようになり、ペットの健康状態の改善につながります。

景気後退

景気後退は、動物病院ヘルスケア市場に大きな影響を与える可能性があります。厳しい経済状況下では、ペットの飼い主は獣医療を含む必要以外の出費を抑え、より安価な代替医療を選んだり、定期的な受診を遅らせたりすることがあります。その結果、動物医療サービスや製品に対する需要が減少し、最終的には動物病院や製薬企業の収益に影響を与えることになります。しかし、景気の先行き不透明感から、消費者が新しいペットを飼うのを延期したり、見送ったりするようになり、需要がさらに落ち込む可能性もあります。

動物医療の進歩

MRIやCTスキャンなどの高度な画像技術などの革新は、動物の複雑な病態をより正確に診断することを可能にします。医薬品の開発により、副作用の少ないより効果的な薬が利用できるようになり、動物の治療成績と生活の質が向上しています。さらに、低侵襲手術技術により、回復時間や術後の合併症が減少し、獣医療はさらに進歩しています。遠隔医療を統合することで、遠隔地からの診察やモニタリングが可能になり、特に十分なサービスを受けていない地域における獣医療サービスへのアクセスが向上しています。

獣医師の不足

ケアを提供できる専門家の数が減ることで、既存の獣医師への負担が増大し、予約の待ち時間が長くなり、獣医療サービスへのアクセスが低下し、開業医が多忙になることでケアの質が低下する可能性があります。しかし、この獣医師不足はまた、十分なサービスを受けていない地域への獣医師診療所の拡大を制限し、コンパニオンアニマルおよび家畜のヘルスケアへのアクセスの格差を悪化させる。研究を推進し、進歩を実施できる専門家が少ないため、この分野での革新的な治療や技術の開発と導入が制限されます。

COVID-19の影響：

COVID-19の大流行は獣医ヘルスケア市場に大きな影響を与えました。ペットの飼い主の行動に顕著な変化が見られ、多くの人がロックダウン中に家で過ごす時間が増え、ペットの健康と幸福への関心が高まったからです。このようなペット飼育の急増とペットの健康への関心は、予防ケア、ワクチン接種、遠隔医療相談などの獣医療サービスに対する需要の高まりにつながった。しかしその反面、規制や安全対策によって一部の動物病院が一時的に閉鎖され、対面診療が減少したため、日常的な処置や緊急性のないケアに影響が出ました。

予測期間中、アレルギー分野が最大となる見込み

予測期間中、アレルギー分野が最大となる見込み。ペットの飼育数が世界的に増加するにつれ、アレルギーを含むペットの健康問題に対する認識も高まっています。このような認識により、ペット専用のアレルギー治療、診断、低アレルギー性製品の研究開発への投資が増加しています。動物病院は、アレルギー検査や治療オプションを含むサービスを拡大しており、毛皮で覆われた同胞のための包括的なケアを求める飼い主を惹きつけています。さらに、製薬会社はペットのアレルギーをターゲットにした新しい薬やワクチンを発表しており、市場の成長をさらに促進しています。

予測期間中にCAGRが最も高くなると予想されるのは動物病院部門です。

動物病院分野は、ペット、家畜、エキゾチックアニマルを含む様々な動物種に特化した医薬品、サプリメント、その他のヘルスケア製品を幅広く提供しているため、予測期間中に最も高いCAGRが見込まれます。これらの薬局は、動物用医薬品に特化することで、従来の人間用の薬局では容易に入手できないような重要な医薬品を確実に入手できるようにしています。さらに、動物薬局は動物の健康に関する専門知識を持つスタッフを雇用していることが多く、ペットの飼い主や家畜生産者に個別の指導やアドバイスを提供することができます。

最大のシェアを持つ地域

北米地域は、動物病院への投資の増加により、ペットのための高度な診断ツール、治療オプション、専門的なケアサービスを備えた最先端施設の設立につながっているため、推定期間を通じて最大の市場シェアを維持する予定です。動物病院の地域的拡大は、動物の質の高いヘルスケアへのアクセスを向上させるだけでなく、獣医療における技術革新も促進しています。予防医療、早期発見、高度な治療に重点を置くこれらの病院は、この地域の動物医療の水準を高めています。

CAGRが最も高い地域：

アジア太平洋地域は、動物用医薬品とサービスの安全性、有効性、品質を確保することで、予測期間中に有益な成長を遂げると推定されます。政府の規制には、動物用医薬品やヘルスケア製品の登録、製造、流通、販売に関するガイドラインが含まれることが多いです。厳格な規制基準を施行することにより、政府は業界内の透明性と説明責任を促進し、地域全体の消費者と利害関係者の信頼を醸成しています。

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• エンドユーザー分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の獣医ヘルスケア市場：製品別

• 治療薬/医薬品
• 診断ツール
• その他の製品

第6章 世界の獣医ヘルスケア市場：疾病別

• 消化器疾患
• アレルギー
• 関節炎

第7章 世界の獣医ヘルスケア市場：エンドユーザー別

• 獣医薬局
• 獣医病院
• その他のエンドユーザー

第8章 世界の獣医ヘルスケア市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイリング

• Zoetis Animal Healthcare
• Ceva Animal Health Inc
• Elanco Animal Health
• Phibro Animal Health
• Boehringer Ingelheim International GmbH
• SeQuent Scientific Ltd
• Cargill Inc
• MSD Animal Health
• Sanofi-Aventis
• Bayer Healthcare
• Novartis International AG

List of Tables

• Table 1 Global Veterinary Healthcare Market Outlook, By Region (2022-2030) ($MN)
• Table 2 Global Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
• Table 3 Global Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
• Table 4 Global Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
• Table 5 Global Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
• Table 6 Global Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
• Table 7 Global Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
• Table 8 Global Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
• Table 9 Global Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
• Table 10 Global Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
• Table 11 Global Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
• Table 12 Global Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
• Table 13 Global Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 14 North America Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
• Table 15 North America Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
• Table 16 North America Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
• Table 17 North America Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
• Table 18 North America Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
• Table 19 North America Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
• Table 20 North America Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
• Table 21 North America Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
• Table 22 North America Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
• Table 23 North America Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
• Table 24 North America Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
• Table 25 North America Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
• Table 26 North America Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 27 Europe Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
• Table 28 Europe Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
• Table 29 Europe Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
• Table 30 Europe Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
• Table 31 Europe Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
• Table 32 Europe Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
• Table 33 Europe Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
• Table 34 Europe Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
• Table 35 Europe Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
• Table 36 Europe Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
• Table 37 Europe Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
• Table 38 Europe Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
• Table 39 Europe Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 40 Asia Pacific Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
• Table 41 Asia Pacific Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
• Table 42 Asia Pacific Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
• Table 43 Asia Pacific Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
• Table 44 Asia Pacific Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
• Table 45 Asia Pacific Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
• Table 46 Asia Pacific Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
• Table 47 Asia Pacific Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
• Table 48 Asia Pacific Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
• Table 49 Asia Pacific Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
• Table 50 Asia Pacific Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
• Table 51 Asia Pacific Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
• Table 52 Asia Pacific Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 53 South America Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
• Table 54 South America Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
• Table 55 South America Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
• Table 56 South America Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
• Table 57 South America Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
• Table 58 South America Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
• Table 59 South America Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
• Table 60 South America Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
• Table 61 South America Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
• Table 62 South America Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
• Table 63 South America Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
• Table 64 South America Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
• Table 65 South America Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 66 Middle East & Africa Veterinary Healthcare Market Outlook, By Country (2022-2030) ($MN)
• Table 67 Middle East & Africa Veterinary Healthcare Market Outlook, By Product (2022-2030) ($MN)
• Table 68 Middle East & Africa Veterinary Healthcare Market Outlook, By Therapeutics/Drugs (2022-2030) ($MN)
• Table 69 Middle East & Africa Veterinary Healthcare Market Outlook, By Diagnostic Tool (2022-2030) ($MN)
• Table 70 Middle East & Africa Veterinary Healthcare Market Outlook, By Other Products (2022-2030) ($MN)
• Table 71 Middle East & Africa Veterinary Healthcare Market Outlook, By Disease (2022-2030) ($MN)
• Table 72 Middle East & Africa Veterinary Healthcare Market Outlook, By Gastrointestinal Diseases (2022-2030) ($MN)
• Table 73 Middle East & Africa Veterinary Healthcare Market Outlook, By Allergies (2022-2030) ($MN)
• Table 74 Middle East & Africa Veterinary Healthcare Market Outlook, By Arthritis (2022-2030) ($MN)
• Table 75 Middle East & Africa Veterinary Healthcare Market Outlook, By End User (2022-2030) ($MN)
• Table 76 Middle East & Africa Veterinary Healthcare Market Outlook, By Veterinary Pharmacies (2022-2030) ($MN)
• Table 77 Middle East & Africa Veterinary Healthcare Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
• Table 78 Middle East & Africa Veterinary Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)

According to Stratistics MRC, the Global Veterinary Healthcare Market is accounted for $46.07 billion in 2024 and is expected to reach $86.69 billion by 2030 growing at a CAGR of 11.11% during the forecast period. Veterinary healthcare encompasses a broad spectrum of medical services aimed at promoting the well-being and health of animals. It involves preventive measures, diagnostics, treatment, and rehabilitation for various animal species, including pets, livestock, wildlife, and exotic animals. Veterinarians play a crucial role in safeguarding animal welfare, public health, and the environment through their expertise in areas such as surgery, internal medicine, dentistry, nutrition, and behavior. Their responsibilities extend beyond individual animal care to disease control, vaccination programs, and research aimed at advancing medical knowledge and improving healthcare outcomes.

According to the American Pet Products Association, veterinary care spending has been steadily rising, with U.S. consumers spent US$ 123.6 billion in 2021 on veterinarian care and product sales.

Market Dynamics:

Driver:

Rise in pet insurance coverage

With more individuals opting for pet insurance plans, there's an increased willingness to seek veterinary care, even for non-emergency situations. This shift reduces financial barriers that might otherwise deter pet owners from seeking preventive or routine medical attention for their animals. Consequently, veterinarians experience higher patient volumes, enabling them to invest in advanced equipment, facilities, and training, thereby elevating the overall quality of care. Moreover, insurance coverage incentivizes pet owners to adhere to treatment plans and follow-up appointments, leading to better health outcomes for their pets.

Restraint:

Economic downturns

Economic downturns can significantly impact the veterinary healthcare market. During tough economic times, pet owners may cut back on non-essential expenditures, including veterinary care, opting for cheaper alternatives or delaying routine visits. This leads to reduced demand for veterinary services and products, ultimately affecting the revenue streams of veterinary clinics and pharmaceutical companies. However, economic uncertainty may prompt consumers to postpone or forego adopting new pets, further dampening demand.

Opportunity:

Advancements in veterinary medicine

Innovations such as advanced imaging technologies like MRI and CT scans enable more accurate diagnoses of complex conditions in animals. Developments in pharmaceuticals have led to the availability of more effective medications with fewer side effects, improving treatment outcomes and quality of life for animals. Moreover, minimally invasive surgical techniques have reduced recovery times and post-operative complications, further advancing veterinary care. The integration of telemedicine allows for remote consultations and monitoring, increasing accessibility to veterinary services, particularly in underserved areas.

Threat:

Shortage of veterinarians

With fewer professionals available to provide care, there's an increased burden on existing veterinarians, leading to longer wait times for appointments, reduced accessibility to veterinary services, and potentially compromised quality of care due to overwhelmed practitioners. However, this shortage also limits the expansion of veterinary practices into underserved areas, exacerbating disparities in access to healthcare for both companion animals and livestock. It restricts the development and adoption of innovative treatments and technologies within the field, as there are fewer experts available to drive research and implement advancements.

Covid-19 Impact:

The Covid-19 pandemic significantly impacted the veterinary healthcare market as there was a noticeable shift in pet owner behavior, with many people spending more time at home during lockdowns, leading to increased attention to their pets' health and well-being. This surge in pet ownership and concern for pet health translated into higher demand for veterinary services, including preventive care, vaccinations, and telemedicine consultations. However, on the flip side, restrictions and safety measures also led to temporary closures of some veterinary clinics and reduced in-person visits, affecting routine procedures and non-urgent care.

The Allergies segment is expected to be the largest during the forecast period

Allergies segment is expected to be the largest during the forecast period. As pet ownership rises globally, so does awareness of pet health issues, including allergies. This awareness has led to increased investment in research and development of allergy treatments, diagnostics, and hypoallergenic products tailored specifically for pets. Veterinary clinics are expanding their services to include allergy testing and treatment options, attracting pet owners seeking comprehensive care for their furry companions. Moreover, pharmaceutical companies are introducing new medications and vaccines targeting pet allergies, further fueling market growth.

The Veterinary Pharmacies segment is expected to have the highest CAGR during the forecast period

Veterinary Pharmacies segment is expected to have the highest CAGR during the forecast period as these pharmacies offer a wide range of medications, supplements, and other healthcare products specifically formulated for various species, including pets, livestock, and exotic animals. By focusing solely on veterinary medications, these pharmacies ensure the availability of essential drugs that may not be readily accessible in traditional human pharmacies. Moreover, veterinary pharmacies often employ staff with expertise in animal health, enabling them to offer personalized guidance and advice to pet owners and livestock producers.

Region with largest share:

North America region is poised to hold the largest market share throughout the estimated period of time as these increasing investments in veterinary hospitals are leading to the establishment of state-of-the-art facilities equipped with advanced diagnostic tools, treatment options, and specialized care services for pets. The regional expansion of veterinary hospitals is not only improving access to quality healthcare for animals but also driving innovation in veterinary medicine. With a focus on preventive care, early detection, and advanced treatments, these hospitals are raising the standard of veterinary healthcare in the region.

Region with highest CAGR:

Asia Pacific region is estimated to gain profitable growth over the extrapolated period by ensuring the safety, efficacy, and quality of veterinary products and services. Government regulations often include guidelines for the registration, manufacturing, distribution, and marketing of veterinary medicines and healthcare products. By enforcing stringent regulatory standards, governments promote transparency and accountability within the industry, fostering trust among consumers and stakeholders across the region.

Key players in the market

Some of the key players in Veterinary Healthcare market include Zoetis Animal Healthcare, Ceva Animal Health Inc, Elanco Animal Health, Phibro Animal Health, Boehringer Ingelheim International GmbH, SeQuent Scientific Ltd, Cargill Inc, MSD Animal Health, Sanofi-Aventis, Bayer Healthcare and Novartis International AG.

Key Developments:

In September 2022, Merck Animal Health announced the new label indication for both Bravectoand BravectoPlus for topical use in cats to treat and control Asian long-horned tick infestations. Bravectoand BravectoPlus for cats is the first and only U.S. product labeled for treatment and control.

In January 2022, Zoetis announced that the U.S. Food and Drug Administration (FDA) had approved a new label indication for SimparicaTrio (sarolaner, moxidectin, and pyrantel chewable tablets) for the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks (black-legged or deer ticks). SimparicaTrio is approved for dogs eight weeks of age and older.

Products Covered:

• Therapeutics/Drugs
• Diagnostic Tool
• Other Products

Diseases Covered:

• Gastrointestinal Diseases
• Allergies
• Arthritis

End Users Covered:

• Veterinary Pharmacies
• Veterinary Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Veterinary Healthcare Market, By Product

• 5.1 Introduction
• 5.2 Therapeutics/Drugs
• 5.3 Diagnostic Tool
• 5.4 Other Products

6 Global Veterinary Healthcare Market, By Disease

• 6.1 Introduction
• 6.2 Gastrointestinal Diseases
• 6.3 Allergies
• 6.4 Arthritis

7 Global Veterinary Healthcare Market, By End User

• 7.1 Introduction
• 7.2 Veterinary Pharmacies
• 7.3 Veterinary Hospitals
• 7.4 Other End Users

8 Global Veterinary Healthcare Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Zoetis Animal Healthcare
• 10.2 Ceva Animal Health Inc
• 10.3 Elanco Animal Health
• 10.4 Phibro Animal Health
• 10.5 Boehringer Ingelheim International GmbH
• 10.6 SeQuent Scientific Ltd
• 10.7 Cargill Inc
• 10.8 MSD Animal Health
• 10.9 Sanofi-Aventis
• 10.10 Bayer Healthcare
• 10.11 Novartis International AG